Welcome

Mintage Scientific's strategy is to support projects and companies which cannot yet establish themselves as self-dependent actors on the venture capital market, or those who lack strength to uphold the collective resources necessary to support and protect their product in critical processes, such as seeking industrial partners or living up to the certification demands of patent offices and society.

Mintage Scientific involves itself with its holdings by finances of seed and bridge type in the early phases and also through Board activity, management and specialised competence during the holding period.  Divestment of the holdings is to be seen as a natural part of the accumulation of value; the Company strives for such forward planning and quality that new share issues and sales can be performed under terms optimising the development of the shareholders' value.    

Our portfolio

Vicore Pharma AB is active in the development of pharmaceuticals. The company owns patented pharmaceutical substances within the Renin Angiotensin System (RAS)

> Read more about Vicore Pharma

I-Tech AB acts within the marine paint industry. The company develops substances to prevent marine hard fouling on boat and ship hulls.

> Read more about I-Tech